Diabete Mellitus Clinical Trial
Official title:
An Observational Pilot Study to Develop a Behavioral Economics Electronic Health Record Module to Guide the Care of Older Adults With Diabetes
NCT number | NCT03409523 |
Other study ID # | 17-01308 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | January 8, 2018 |
Est. completion date | July 3, 2019 |
Verified date | July 2019 |
Source | NYU Langone Health |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study will develop a new electronic health record module to improve guideline-compliant
care of older adults with diabetes. The module will incorporate effective behavioral
economics (BE) principles to improve the degree to which care of older adults is compliant
with Choosing Wisely guidelines; this generally involves less aggressive targets for HbA1c,
and reductions of medications other than metformin.
The implementation of the module will ultimately be triggered by medication prescribing in
EPIC. The BE principles include suggesting alternatives to medications, requiring
justification, setting of appropriate default order sets, and incorporation of anchoring and
checklists to guide behavior. The study will involve provider workflow analysis based on
observation, module user testing, and live usability testing with direct observation and
semi-structure interviews.
Status | Completed |
Enrollment | 30 |
Est. completion date | July 3, 2019 |
Est. primary completion date | July 3, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 21 Years to 90 Years |
Eligibility |
Inclusion Criteria: - Providers in NYU outpatient primary care, geriatrics, or endocrine clinics at NYU who care for older adults with diabetes Exclusion Criteria: - None |
Country | Name | City | State |
---|---|---|---|
United States | New York University School of Medicine | New York | New York |
Lead Sponsor | Collaborator |
---|---|
NYU Langone Health |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Compliance with Choosing Wisely guidelines measured by number of reductions of medications | The implementation of the module will ultimately be triggered by medication prescribing in EPIC. | 60 Months | |
Secondary | Usability measured by module user testing with direct observation and semi structured interviews | 60 Months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05563090 -
Investigating the Syndrome Differentiation of Diabetic and Pre-diabetic Using Digitalized TCM Diagnostic Tools
|
||
Recruiting |
NCT05333159 -
The Efficacy of SGLT-2 Inhibitor in Patients With CAD and DM Undergoing PCI.
|
||
Active, not recruiting |
NCT03119584 -
Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation
|
Phase 4 | |
Completed |
NCT04409171 -
Glucose Metabolism After Partial Pancreatectomy
|
||
Recruiting |
NCT06060392 -
Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus
|
N/A | |
Completed |
NCT05144971 -
StatStrip A Glucose/Creatinine Meter System Lay User Study Evaluation
|
||
Completed |
NCT03914183 -
Can mCPN Intervention Improve Injection Site Rotation
|
N/A | |
Completed |
NCT03781232 -
Non-invasive Glucose Measurement With Raman Technology in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
Not yet recruiting |
NCT06150508 -
Randomized Controlled Trial of the Smart O2O Model Development for Chronic Diseases Management Through Digital Health
|
N/A | |
Completed |
NCT01252810 -
Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure
|
Phase 2 | |
Active, not recruiting |
NCT04171557 -
Bicycling and Mortality Among Individuals With diabetesNutrition (EPIC)
|
||
Active, not recruiting |
NCT03155594 -
CGM to Aid Transition From Inpatient to Outpatient
|
N/A | |
Completed |
NCT04864327 -
Smoking Intervention Among Patients With Diabetes
|
N/A | |
Completed |
NCT04407182 -
Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19
|
Phase 2 | |
Completed |
NCT05752591 -
Hypothalamic-pituitary Dysfunction in Diabetes
|
||
Completed |
NCT03159546 -
FreeStyle Libre Flash Glucose Monitoring System Accuracy
|
N/A | |
Completed |
NCT03953092 -
A Randomized, Double-blind, Placebo-controlled, Sequential Single and Multiple Ascending Doses of YG1699
|
Phase 1 | |
Not yet recruiting |
NCT06262854 -
Efficacy and Safety of Stimulan® for the Treatment of Diabetic Foot Osteomyelitis. The BIG D-FOOT Study
|
N/A | |
Completed |
NCT03934281 -
Study of the Value of Using a Honey Dressing Compared to the Use of a Standard Dressing on the Toe Amputation Wound in the Diabetic Patient
|
N/A | |
Not yet recruiting |
NCT03341026 -
Metronom Continuous Glucose Monitoring System
|
N/A |